Poly Medicure Limited’s Board of Directors convened on August 7, 2026, approving the unaudited financial results for the first quarter ended June 30, 2026. The meeting also saw the Nomination & Remuneration Committee approve a grant of 1,476 stock options and the allotment of 1,975 equity shares to eligible employees under its ESOP Scheme 2020. The company also re-appointed M/s Jai Prakash & Company as Cost Auditors and noted the resignation of its Deputy Company Secretary.
Poly Medicure Board Meeting Outcomes
On August 7, 2026, Poly Medicure Limited held a Board meeting where key financial and operational decisions were made. The Board approved the unaudited financial results, both standalone and consolidated, for the first quarter that concluded on June 30, 2026. Detailed review reports are attached to the disclosure.
Employee Stock Option Scheme (ESOP) Updates
The Nomination & Remuneration Committee approved two significant actions related to employee incentives:
- Grant of Stock Options: A grant of 1,476 Stock Options was approved under the Poly Medicure Limited Employee Stock Option Scheme 2020, for eligible employees.
- Allotment of Equity Shares: The committee also approved the allotment of 1,975 Equity Shares, each with a face value of ₹5, to employees who exercised their options under the ESOP Scheme 2020. This allotment increased the company’s paid-up equity share capital to ₹50,68,07,325 (10,13,61,465 equity shares).
Cost Auditors Re-appointment and Personnel Changes
Further decisions from the Board meeting include:
- Cost Auditors: M/s. Jai Prakash & Company has been re-appointed as the Cost Auditors for the Financial Year 2026-27.
- Resignation: Mr. Ravi Prakash tendered his resignation as Deputy Company Secretary and Compliance Officer, effective August 10, 2026, to pursue other career opportunities.
Financial Highlights
The financial results for the quarter ended June 30, 2026, show standalone profit after tax of ₹8,062.17 lacs and consolidated profit after tax of ₹8,527.43 lacs. Total comprehensive income for the standalone and consolidated entities were ₹8,705.10 lacs and ₹8,523.11 lacs, respectively.
The basic earnings per share for the quarter stood at ₹8.68 (standalone) and ₹8.49 (consolidated).
Source: BSE
